Acarix AB (publ) (ACIXF)

Market Cap	33.60M +50.2%
Revenue (ttm)	798.61K +18.7%
Net Income	-5.22M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	50,252
Open	0.0290
Previous Close	n/a
Day's Range	0.0290 - 0.0290
52-Week Range	0.0090 - 0.0459
Beta	-0.24
RSI	47.48
Earnings Date	Apr 15, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 8
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACIXF

Financial Performance

In 2025, Acarix AB's revenue was 7.36 million, an increase of 18.69% compared to the previous year's 6.20 million. Losses were -48.09 million, -27.34% less than in 2024.

Financial numbers in SEK